Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $144.90 million. The enterprise value is $160.24 million.
| Market Cap | 144.90M |
| Enterprise Value | 160.24M |
Important Dates
The next confirmed earnings date is Thursday, April 25, 2024, before market open.
| Earnings Date | Apr 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.45 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Shares Outstanding | 16.45M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 4.19% |
| Owned by Institutions (%) | 68.59% |
| Float | 10.07M |
Valuation Ratios
The trailing PE ratio is 20.02 and the forward PE ratio is 12.52.
| PE Ratio | 20.02 |
| Forward PE | 12.52 |
| PS Ratio | 0.91 |
| Forward PS | 0.83 |
| PB Ratio | 1.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 22.27 |
| EV / Sales | 1.01 |
| EV / EBITDA | 10.63 |
| EV / EBIT | 14.35 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.20.
| Current Ratio | 3.80 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.70 |
| Debt / FCF | n/a |
| Interest Coverage | 5.54 |
Financial Efficiency
Return on equity (ROE) is 6.00% and return on invested capital (ROIC) is 4.94%.
| Return on Equity (ROE) | 6.00% |
| Return on Assets (ROA) | 4.10% |
| Return on Capital (ROIC) | 4.94% |
| Revenue Per Employee | $295,978 |
| Profits Per Employee | $13,427 |
| Employee Count | 536 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 2.86 |
Taxes
In the past 12 months, Ultralife has paid $1.95 million in taxes.
| Income Tax | 1.95M |
| Effective Tax Rate | 21.33% |
Stock Price Statistics
The stock price has increased by +118.07% in the last 52 weeks. The beta is 1.25, so Ultralife's price volatility has been higher than the market average.
| Beta (1Y) | 1.25 |
| 52-Week Price Change | +118.07% |
| 50-Day Moving Average | 8.98 |
| 200-Day Moving Average | 8.21 |
| Relative Strength Index (RSI) | 46.97 |
| Average Volume (30 Days) | 60,148 |
Short Selling Information
The latest short interest is 105,551, so 0.64% of the outstanding shares have been sold short.
| Short Interest | 105,551 |
| Short Previous Month | 128,879 |
| Short % of Shares Out | 0.64% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
In the last 12 months, Ultralife had revenue of $158.64 million and earned $7.20 million in profits. Earnings per share was $0.44.
| Revenue | 158.64M |
| Gross Profit | 39.20M |
| Operating Income | 9.48M |
| Pretax Income | 9.15M |
| Net Income | 7.20M |
| EBITDA | 15.08M |
| EBIT | 11.16M |
| Earnings Per Share (EPS) | $0.44 |
Balance Sheet
The company has $10.28 million in cash and $25.62 million in debt, giving a net cash position of -$15.35 million or -$0.93 per share.
| Cash & Cash Equivalents | 10.28M |
| Total Debt | 25.62M |
| Net Cash | -15.35M |
| Net Cash Per Share | -$0.93 |
| Equity / Book Value | 125.33M |
| Book Value Per Share | 7.62 |
| Working Capital | 66.47M |
Cash Flow
In the last 12 months, operating cash flow was $1.93 million and capital expenditures -$2.55 million, giving a free cash flow of -$623,000.
| Operating Cash Flow | 1.93M |
| Capital Expenditures | -2.55M |
| Free Cash Flow | -623,000 |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 24.71%, with operating and profit margins of 5.97% and 4.54%.
| Gross Margin | 24.71% |
| Operating Margin | 5.97% |
| Pretax Margin | 5.77% |
| Profit Margin | 4.54% |
| EBITDA Margin | 9.50% |
| EBIT Margin | 7.04% |
| FCF Margin | -0.39% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | 4.97% |
| FCF Yield | -0.43% |
Analyst Forecast
The average price target for Ultralife is $13.00, which is 47.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.00 |
| Price Target Difference | 47.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 2.87 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 6 |